PBI17 BUDGET IMPACT ANALYSIS OF INTRODUCTION OF RITUXIMAB BIOSIMILAR IN THE UNITED STATES FROM A PAYER PERSPECTIVE
May 1, 2020, 00:00
10.1016/j.jval.2020.04.084
https://www.valueinhealthjournal.com/article/S1098-3015(20)30272-2/fulltext
Title :
PBI17 BUDGET IMPACT ANALYSIS OF INTRODUCTION OF RITUXIMAB BIOSIMILAR IN THE UNITED STATES FROM A PAYER PERSPECTIVE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30272-2&doi=10.1016/j.jval.2020.04.084
First page :
Section Title :
Open access? :
No
Section Order :
10314